Notably, prostatic ALA was positively associated with biomarkers of aggressive prostate cancer (prostate-specific antigen (PSA) and tumor proliferation rates), suggesting that prostatic ALA metabolism may be linked to disease aggressiveness. Here, KLK3 is linked to prostate cancer.